Jushi Holdings (JUSHF) Operating Expenses (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Operating Expenses of $30.8 million for Q2 2026, up 21.7% year-over-year from $25.3 million in Q2 2025, and up 8.91% quarter-over-quarter from $28.3 million in Q1 2026.
Jushi Holdings (JUSHF) Operating Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Operating Expenses for 6 consecutive years, with $30.8 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses rose 21.7% year-over-year to $30.8 million; the TTM figure through Jun 2026 stood at $115.3 million (up 6.7% YoY), while the FY2025 annual figure was $109.1 million, up 1.57% from the prior year.
- Operating Expenses improved to $30.8 million in Q2 2026 per JUSHF's latest filing, from $28.3 million in the prior quarter.
- Across five years, Operating Expenses topped out at $161.2 million in Q4 2022 and bottomed at $24.2 million in Q2 2024.
- Historically, Operating Expenses has averaged $39.5 million across 5 years, with a median of $28.3 million in 2024.
- Annual changes were most pronounced in 2022 — Operating Expenses jumped 252.32% — and 2023, when it sank 79.06%.
- Jushi Holdings' Operating Expenses stood at $161.2 million in 2022, then tumbled by 79.06% to $33.8 million in 2023, then fell by 19.27% to $27.2 million in 2024, then increased by 2.14% to $27.8 million in 2025, then increased by 10.72% to $30.8 million in 2026.
- Business Quant data shows JUSHF's Operating Expenses at $30.8 million in Q2 2026, $28.3 million in Q1 2026, and $27.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 30.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.82 Mn |
| Mar 31, 2026 | 28.29 Mn |
| Dec 31, 2025 | 27.83 Mn |
| Sep 30, 2025 | 28.33 Mn |
| Jun 30, 2025 | 25.32 Mn |
| Mar 31, 2025 | 27.65 Mn |
| Dec 31, 2024 | 27.25 Mn |
| Sep 30, 2024 | 27.82 Mn |
| Jun 30, 2024 | 24.16 Mn |
| Mar 31, 2024 | 28.21 Mn |
| Dec 31, 2023 | 33.75 Mn |
| Sep 30, 2023 | 25.69 Mn |
| Jun 30, 2023 | 27.15 Mn |
| Mar 31, 2023 | 32.45 Mn |
| Dec 31, 2022 | 161.16 Mn |
| Sep 30, 2022 | 78.19 Mn |
| Jun 30, 2022 | 38.75 Mn |
| Mar 31, 2022 | 37.31 Mn |
| Dec 31, 2021 | 45.74 Mn |
| Sep 30, 2021 | 25.15 Mn |